三个皮匠报告—— 严选型全行业研究报告分享下载平台,您的专属行业智库!
欢迎来到三个皮匠报告!
登录
帮助中心
首页
最新
研搜
BETA
合集
英文
会议
数据
财报库
政策库
自研报告
入驻
您的当前位置:
首页
>
行业数据
>
HR2竞争性抑制融合核心序列构建
HR2竞争性抑制融合核心序列构建
行业数据
下载Excel
下载图片
原图定位
图片属性
图片格式:PNG
图片大小:752KB
图片尺寸:1971*714
同报告图片
/
4
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
fCDlubTku70gfCDmr5vliKnnjocgfCDlh4DliKnnjocgfAp8LS0tLS0tfC0tLS0tLS0tfC0tLS0tLS0tfAp8IDIwMTggfCA4NS41NiUgfCAtMjYuOTUlIHwKfCAyMDE5IHwgNzkuNTMlIHwgLTE0NC4wNiUgfAp8IDIwMjAgfCA4MC40OCUgfCAtODQuNDIlIHwKfCAyMDIxIHwgNzIuMDQlIHwgMy44NiUgfAp8IDIwMjJRMS1RMyB8IDc4LjU0JSB8IC0yNy45MiUgfAoK6LWE5paZ5p2l5rqQ77yaaUZpbkTvvIzljY7lronor4HliLjnoJTnqbbmiYA=
fCDlubTku70gfCDlvZLmr43lh4DliKnmtqbvvIjkur/lhYPvvIkgfCDlkIzmr5QgfAp8LS0tLS0tfC0tLS0tLS0tLS0tLS0tLS0tLS0tLS18LS0tLS0tfAp8IDIwMTggfCAtMy40MSAgICAgICAgICAgICAgICB8IC0yMDMuMzUlIHwKfCAyMDE5IHwgLTguODUgICAgICAgICAgICAgICAgfCAtMTU5LjYzJSB8CnwgMjAyMCB8IC02LjA5ICAgICAgICAgICAgICAgIHwgMzEuMTIlIHwKfCAyMDIxIHwgMC4zMSAgICAgICAgICAgICAgICAgfCAxMDUuMDUlIHwKfCAyMDIyUTEtUTMgfCAtMS40NyAgICAgICAgICAgICAgICB8IC0yNC4zMiUgfAoK6LWE5paZ5p2l5rqQ77yaaUZpbkTvvIzljY7lronor4HliLjnoJTnqbbmiYA=
fCDlubTku70gfCDokKXkuJrmgLvmlLblhaXvvIjkur/lhYPvvIkgfCDlkIzmr5QgfAp8LS0tLS0tfC0tLS0tLS0tLS0tLS0tLS0tLXwtLS0tLS18CnwgMjAxOCB8IDEyLjY0ICAgICAgICAgICAgfCAxLjQ2JSB8CnwgMjAxOSB8IDYuMTQgICAgICAgICAgICAgfCAtNTEuNDMlIHwKfCAyMDIwIHwgNy4yMiAgICAgICAgICAgICB8IDE3LjUxJSB8CnwgMjAyMSB8IDcuMzYgICAgICAgICAgICAgfCAxLjk3JSB8CnwgMjAyMlExLVEzIHwgNS4zMSAgICAgICAgICAgICB8IDQuNTglIHwKCui1hOaWmeadpea6kO+8mmlGaW5E77yM5Y2O5a6J6K+B5Yi456CU56m25omA
fCDliLbliYIgfCDljp/mlpnoja8gfCDlm7rkvZPnsbsgfCDlhbbku5bkuJrliqEgfCDlrqLmiLfogr0gfCDljJblpoblk4EgfCDlmajmorDnsbsgfAp8LS0tLS0tfC0tLS0tLS0tfC0tLS0tLS0tfC0tLS0tLS0tLS18LS0tLS0tLS18LS0tLS0tLS18LS0tLS0tLS18CnwgNjAlIHwgMjAlICAgIHwgMTAlICAgIHwgNSUgICAgICAgfCAzJSAgICAgfCAyJSAgICAgfCAwJSAgICAgfAoK6LWE5paZ5p2l5rqQ77ya5YWs5Y+45YWs5ZGK44CB5Y2O5a6J6K+B5Yi456CU56m25omA
所属报告:
翰宇药业-公司研究报告-新冠预防赛道抢占先机多肽基础业务触底反弹-230113(35页).pdf
打包全文图表
相关数据
HR+HER2-乳腺癌治疗数据:SKB264展现超越现有的TROP2ADC市场定位的竞争力(非头对头)
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
收藏
行业数据
2025-10-23
原图定位
查看详情
Atirmociclib联合来曲唑治疗HR+/HER2-mBC1L的有效性和安全性数据
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
收藏
行业数据
2025-08-08
原图定位
查看详情
Vepdegestrantvs氟维司群在HR+/HER2-BC(全人群)的PFS数据
fCDpobnnm64gICAgICAgICAgICAgICAgICAgICB8IFZlcGRlZ2VzdHJhbnQgfCBGdWx2ZXN0cmFudCB8CnwtLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS18LS0tLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tLXwKfCBNZWRpYW4gZm9sbG93LXVwLCBtb250aHMgfCA3LjQgICAgICAgICAgICB8IDcuMiAgICAgICAgICB8CnwgRXZlbnRzLCBuICglKSAgICAgICAgICAgfCAxODYgKDU5KSAgICAgICB8IDE5OCAoNjQpICAgICB8CnwgTWVkaWFuIFBGUywgbW9udGhzICg5NSUgQ0kpIHwgMy43ICgzLjbigJM1LjMpICB8IDMuNiAoMi4y4oCTMy44KXwKfCBTdHJhdGlmaWVkIEhSICg5NSUgQ0kpICAgfCAwLjgzICgwLjY44oCTMS4wMikgfCAgICAgICAgICAgICAgfAp8IDItc2lkZWQgUD0wLjA3ICAgICAgICAgICB8ICAgICAgICAgICAgICAgIHwgICAgICAgICAgICAgIHw=
收藏
行业数据
2025-08-08
原图定位
查看详情
PF-07220060联合Atirmociclib治疗HR+/HER2-mBC后线的有效性数据
fCDpobnnm64gfCDmlbDmja4gfAp8LS0tLS0tfC0tLS0tLXwKfCDlrqLop4LnvJPop6PnjocgfCAyNy44JSB8Cnwg55a+55eF5o6n5Yi2546HIHwgNTUuNiUgfAp8IOS4reS9jVBGUyB8IDguM+S4quaciCB8CgrotYTmlpnmnaXmupDvvJrovonnkZ7lrpjnvZHvvIzlm73kv6Hor4HliLjnu4/mtY7noJTnqbbmiYDmlbTnkIY=
收藏
行业数据
2025-08-08
原图定位
查看详情
SERD全球研发格局(HR+/HER2-BC)
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
收藏
竞争格局
2025-08-08
原图定位
查看详情
SKB264HR+/HER2-BC适应症新增纳入2025CSCO乳腺癌诊疗指南
5aW955qE77yM5Lul5LiL5piv5oKo5Zu+54mH5Lit55qE5pWw5o2u55Sf5oiQ55qE6KGo5qC877yM5bm25Zyo6KGo5qC85LiL5pa55bGV56S65LqG6LWE5paZ5p2l5rqQ77yaCgp8IOWIhuWxgiAgICAgICAgICAgICAgfCBJ57qn5o6o6I2QICAgICAgICAgICB8IElJ57qn5o6o6I2QICAgICAgICAgICB8IElJSee6p+aOqOiNkCAgICAgICAgICAgfAp8LS0tLS0tLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tLS0tLS0tfC0tLS0tLS0tLS0tLS0tLS0tLS0tfC0tLS0tLS0tLS0tLS0tLS0tLS0tLXwKfCBDREs0LzZp5pyq57uP5rK7ICAgICB8IOWGheWIhuazjCtDREs0LzZpKDFBKSB8IOWMlueWlyAgICAgICAgICAgICAgIHwgMS4gRGF0by1EWGQgICAgICAgICB8CnwgICAgICAgICAgICAgICAgICAgfCAxLiBULURYZCAoMUEpICAgICB8IDEuIOaIiOaymeWmpeePoOWNleaKlygxQSkgfCAgICAgICAgICAgICAgICAgICAgIHwKfCBDREs0LzZpIOe7j+ayuyAgICAgfCAyLiDljJbnlpcoMkEpICAgICAgIHwgMi4g6Iqm5bq35rKZ5aal54+g5Y2V5oqXKDJBKSB8IDIuIOenkeWtpuOAgeWQiOeQhuiuvuiuoeeahOS4tOW6iueglOeptiB8CnwgICAgICAgICAgICAgICAgICAgfCAgICAgICAgICAgICAgICAgICB8IDMuIOWFtuS7luWGheWIhuazjCgyQSkgICB8ICAgICAgICAgICAgICAgICAgICAgfAoK6LWE5paZ5p2l5rqQ77ya44CK5Lit5Zu95Li05bqK6IK/55ik5a2m5Lya77yIQ1NDT++8ieS5s+iFuueZjOiviueWl+aMh+WNlyAyMDI144CL77yM56eR5Lym5Y2a5rOw5YWs5LyX5Y+377yM6KW/6YOo6K+B5Yi456CU5Y+R5Lit5b+D
收藏
行业数据
2025-06-30
原图定位
查看详情
HR+/HER2-BC患者数占比高但预后好,HER2+BC及TNBC侵袭性更强
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
收藏
行业数据
2025-06-03
原图定位
查看详情
内分泌治疗与CDK4/6i已成为HR+/HER2-BC全线治疗的基石方案
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
收藏
行业数据
2025-06-03
原图定位
查看详情
CDK4/6i在HR+/HER2-mBC全线均有布局
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
收藏
行业数据
2025-06-03
原图定位
查看详情
2017-2030E全球及中国HR+/HER2-BC发病人数及预测
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
收藏
行业数据
2025-04-14
原图定位
查看详情
7TROP2ADC针对HR+HER2-BC的临床探索展现出优异疗效(非头对头对比)
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
收藏
行业数据
2025-03-14
原图定位
查看详情
BL-B01D1在TNBC、HR+/HER2-以及HER2+乳腺癌等适应症均展现出优异的客观缓解率
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
收藏
行业数据
2025-03-11
原图定位
查看详情
BL-B01D1:中国HR+/HER2-乳腺癌销售额潜力预测简
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
收藏
行业数据
2025-02-06
原图定位
查看详情
BL-B01D1:美国HR+/HER2-乳腺癌销售额潜力预测简
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
收藏
行业数据
2025-02-06
原图定位
查看详情
中国2L+HR+/HER2-乳腺癌市场竞争格局(ADC)
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
收藏
竞争格局
2025-02-06
原图定位
查看详情
最新数据
全球全年龄段奶粉市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球酸奶及发酵乳制品市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球药用级益生菌市场规模(百万美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球益生菌膳食补充剂市场规模及增速
收藏
行业数据
2026-07-30
原图定位
查看详情
全球拥有AKK专利菌株的核心企业
收藏
行业数据
2026-07-30
原图定位
查看详情
中的 HR1 区域结合,抑制六螺旋束形成,进而阻止病毒与细胞间的膜融合,阻断病毒侵入细胞的途径。此机制下多肽与病毒蛋白以共价键结合,抑制病毒作用强,体外活病毒在纳摩尔(nmol)即达到 100%抑制。
行业数据
原图定位
当前图表所属:
翰宇药业-公司研究报告-新冠预防赛道抢占先机多肽基础业务触底反弹-230113(35页).pdf
图表9公司2018-2022Q1-Q3毛利率和净利率(%)
图表8公司2018-2022Q1-Q3归母净利润情况(亿元,%)
公司2018-2022Q1-Q3营收情况(亿元,%)
图表52022年H1营业收入按产品拆分情况
下载图片或Excel,需升级至尊VIP会员或「预见者」VIP
立即去升级
客服
商务合作
小程序
服务号
回到顶部
折叠
微信扫码登录
微信扫码登录
双重福利,扫码领取!
关注公众号『三个皮匠报告』,免费领取报告
1.100+最新优质行业报告
2.每周免费精选报告分享
手机快捷登录
账号登录
记住密码
忘记密码?
验证即登录,未注册将自动创建账号
获取验证码
收不到验证码注意事项
登录代表您已阅读并同意
《三个皮匠服务条款》